PLoS ONE: Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study
Conclusions/Significance
The
risk of mortality was not associated with HT duration, type or age at
initiation. It was however not equal across all women, with some women
appearing genetically more vulnerable to the effects of HT in terms of
their estrogen receptor genotype. These findings, if confirmed in
another independent study, may help explain the differential
susceptibility of women to the beneficial or adverse effects of HT.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.